H19 and breast carcinoma: Similarly Lu et al. [106] demonstrated a higher expression (3-fold) of H19 in ERα-positive breast cancer patients (n = 76) than in ERα-negative breast cancer patients (n = 53), which suggests a possible involvement of ERα in the up-regulation of H19 in chemoresistant cancer cells.